Form 8-K - Current report:
SEC Accession No. 0001104659-25-111278
Filing Date
2025-11-13
Accepted
2025-11-13 16:07:10
Documents
15
Period of Report
2025-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2530872d1_8k.htm   iXBRL 8-K 45244
2 EXHIBIT 10.1 tm2530872d1_ex10-1.htm EX-10.1 1070699
6 GRAPHIC tm2530872d1_img001.jpg GRAPHIC 3527
7 GRAPHIC tm2530872d1_ex10-1img001.jpg GRAPHIC 3532
  Complete submission text file 0001104659-25-111278.txt   1533548

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idxx-20251112.xsd EX-101.SCH 3005
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20251112_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20251112_pre.xml EX-101.PRE 22352
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2530872d1_8k_htm.xml XML 3566
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 251478422
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)